Weekly NIH Funding Opportunities and Notices - 2024

March 29, April 05, April 12, and April 19.

SBIR and STTR Funding Opportunities | Seed

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. NIH advertises the availability of grant support through notices of funding opportunities (NOFOs), previously referred to as funding opportunity announcements (FOAs). Standard Application Due Dates: September 5, January 5, and April 5. Due dates that fall on weekends or Federal holidays move to the next business day.

Funding Opportunities: Department of Defense - Chronic Pain Management Research Program, Combat Casualty Care Research Program, Defense Medical Research and Development Program, Kidney Cancer Research Program and Vision Research Program

All pre-applications must be submitted electronically to the Electronic Biomedical Research Application Portal (eBRAP) https://ebrap.org.

NCI SBIR/STTR Omnibus Grant Solicitations

SBIR/STTR Omnibus Solicitations are intended to support small business innovation research across a broad spectrum of topic areas. For the full program description and research topics, please read the 2023 Omnibus Solicitation Program Description.

CDMRP Pre-announcements

Traumatic Brain Injury and Psychological Health

This is to notify the research community of recently released Fiscal Year 2024 (FY24) pre-announcement for the Department of Defense (DOD) Traumatic Brain Injury and Psychological Health Research Program managed by the Congressionally Directed Medical Research Programs (CDMRP).

The FY24 Defense Appropriations Bill has not been signed into law. Although FY24 funds have not been appropriated, CDMRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to anticipated FY24 funding opportunities. This pre-announcement should not be construed as an obligation by the government.

The Traumatic Brain Injury and Psychological Health Research Program has released a pre-announcement for the following funding opportunities:

Clinical Trial Award
Emerging Research Award *New for FY24
Focused Program Award
Health Services Research Award
Translational Research Award

FY24 DOD Peer Reviewed Orthopaedic Research Program Pre-Announcement

This is to notify the research community of a recently released Fiscal Year 2024 (FY24) pre-announcement for a Department of Defense (DOD) program managed by the Congressionally Directed Medical Research Programs (CDMRP).

FY24 Pre-announcement released:

The FY24 Peer Reviewed Orthopaedic Research Program (PRORP) released a pre-announcement for the following funding opportunities:

Applied Research Award
Clinical Translational Research Award
Clinical Trial Award
Women’s Health Research Award *New for FY24*

Multiple Sclerosis

The Multiple Sclerosis Research Program released a pre-announcement for the following funding opportunities:

Clinical Trial Award
Early Investigator Research Award
Exploration – Hypothesis Development Award – New Investigator Option
Investigator – Initiated Research Award – New Investigator Option

Pancreatic Cancer

The Pancreatic Cancer Research Program released a pre-announcement for the following funding opportunities:

Focused Pilot Award
Idea Development Award
Idea Development Award – Early Career Investigator Option
Translational Research Partnership Award

Tick-Borne Disease Research Program Pre-Announcement

FY24 Pre-announcement released:

The Tick-Borne Disease Research Program (TBDRP) released a pre-announcement for the following funding opportunities:

Idea Development Award
Therapeutic/Diagnostic Research Award

CDMRP Breast Cancer

Department of Defense Congressionally Directed Medical Research Programs - Breast Cancer Research Program (BCRP) - Anticipated Funding Opportunity for Fiscal Year 2024 (FY24).

Although FY24 funds have not been appropriated, CDMRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to anticipated FY24 funding opportunities. This pre-announcement should not be construed as an obligation by the government.

FY24 Pre-announcement released:

The Breast Cancer Research Program (BCRP) released a pre-announcement for the following funding opportunities:

Breakthrough Award Levels 1 and 2
Breakthrough Award Level 3
Breakthrough Award Level 4
Era of Hope Scholar Award
Clinical Research Extension Award
Transformative Breast Cancer Consortium Development Award
Transformative Breast Cancer Consortium Award

Ovarian Cancer

Department of Defense Congressionally Directed Medical Research Programs - Ovarian Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2024 (FY24) Although FY24 funds have not been appropriated, CDMRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to anticipated FY24 funding opportunities. This pre-announcement should not be construed as an obligation by the government.

FY24 Pre-announcements released:

The Ovarian Cancer Research Program (OCRP) released a pre-announcement for the following funding opportunities:

Pilot Award
Investigator- Initiated Research Award
Clinical Trial Award
Clinical Trial Translational Endpoints Award ** (NEW)
Ovarian Cancer Academy – Leadership Award ** (NEW)
Ovarian Cancer Academy – Early-Career Investigator Award
Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award** (NEW)

Amyotrophic Lateral Sclerosis

Department of Defense Congressionally Directed Medical Research Programs - Amyotrophic Lateral Sclerosis Research Program Anticipated Funding Opportunities for Fiscal Year 2024 (FY24). Although FY24 funds have not been appropriated, CDMRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to anticipated FY24 funding opportunities. This pre-announcement should not be construed as an obligation by the government.

FY24 Pre-announcements released:

The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released a pre-announcement for the following funding opportunities:

Clinical Outcomes and Biomarkers Award
Pilot Clinical Trial Award
Therapeutic Development
Therapeutic Idea Award

The Peer Reviewed Alzheimer’s Research Program (PRARP) released a pre-announcement for the following funding opportunities:

Transforming Care Award
Transforming Diagnosis Award
Transforming Research Award

Non-Federal Funding Opportunities

Emerging Leader Award

Emerging Leader Award | The Mark Foundation for Cancer Research

Due April 29, 2024
Amount: $750,000 over three years These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. This award is not intended to be the main source of funding for the applicant’s lab. Applicants must demonstrate multi-year independent funding that sustains the central activities of the lab.

Projects must be centered on evidence-based laboratory, data, and/or medical science.

Eligibility: MD, PhD or equivalent is required; Must be 3 to 8 years from the start of an independent faculty research appointment as of 12/31/2024.

Crohn's and Colitis Research Foundation: Senior Research Awards

Due: May 6, 2024 (LOI)

Amount: $390,000 over 3 years
Notes: To support established researchers for research relevant to Inflammatory Bowel Disease (IBD) or Crohn's disease and/or ulcerative colitis. Funding should be used to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institutes of Health (NIH). Applicants must hold an MD and/or PhD (or equivalent). Eligibility is not restricted by citizenship.
Link: Senior Research Awards | Crohn's & Colitis Foundation (crohnscolitisfoundation.org).

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

National Multiple Sclerosis Society: Career Transition Fellowships

Due: May 10, 2024 (pre-application)

Amount: $600,000 over 5 years
Notes: To foster the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The award provides approximately $600,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment. Applicants must have more than two years of postdoctoral research experience and no more than five years of postdoctoral research experience at the time of application.
Link: Career Transition Fellowships | National MS Society

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Robert Winn Award

Robert A. Winn Diversity in Clinical Trials Career Development Award

Due: May 14, 2024
Amount: $240,000/2 years
Clinical research areas include cancer (hematology and oncology), cardiovascular disease and immunologic disorders. The award is designed to support the career development of early-stage investigator physicians from diverse backgrounds, and physicians with a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators engaged in advancing health equity. Grantees are required to receive mentorship from a seasoned clinical investigator at a clinical trial site or institution and are expected to actively participate in their mentor’s clinical trial, which must meet the FDA Clinical Trial Definition. Scholars aren’t expected to run their own trials.
Eligibility: Candidates must hold the degree of either MD, MD/PhD, DO or DO/PhD. Must be US citizen, permanent resident, or hold an H-1B or O-1 visa, which must be valid during the full award period. Must have completed terminal research degree or medical residency (whichever later) within the past 10 years. You don’t have to fall under URM population to participate; you may apply with a demonstrated commitment to increasing diverse patient populations in clinical trials. A mentor who will provide guidance on career development focusing on challenges, opportunities, and strategies for researchers from underserved backgrounds is required.

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

Freeman Hrabowski

Freeman Hrabowski Scholars Program | Howard Hughes Medical Institute

Due: May 15, 2024
Amount: Up to $8.6M over 10 years
Notes: to support outstanding basic researchers, including physician-scientists, who have strong potential to become leaders in their fields and to advance diversity, equity, and inclusion through their mentoring efforts and understanding of systemic exclusion and marginalization in science of trainees from different backgrounds. Scholars prioritize scientific excellence in their own research while creating an inclusive lab climate that serves as a model within their own institutions and beyond. Freeman Hrabowski Scholars are employed by HHMI and maintain an academic appointment and lab at their research institutions. Scholars are required to spend at least 80 percent of their time on their research.
Eligibility: PI must hold MD or PhD or equivalent; began their first post-training position and a tenure-track (or equivalent) faculty position on or after March 1, 2020, or have accepted an offer for a tenure-track (or equivalent) position that begins no later than March 1, 2025; have a research focus in the biological and biomedical sciences.
Link: Freeman Hrabowski Scholars Program | HHMI

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

March of Dimes

March of Dimes: Reproductive Scientist Development Program

Due: May 15, 2024 (LOI)
Amount: $250,000 over 2 years
Notes: Proposed research “must be translational in nature and relate to the field of maternal fetal health – with a focus on prematurity, maternal and infant morbidity and mortality and health equity.” PI Must be seeking a career in academic obstetrics and gynecology research. Applicants must be near completion of their residency in obstetrics and gynecology or in their subspecialty fellowship. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Prior laboratory experience is not required.
Link: Reproductive Scientist Development Program | March of Dimes

For further details, please contact Audrey Mcinerney (amcinerney@montefiore.org).

AACR

Victoria's Secret Global Fund for Women's Cancers Career Development Award, in partnership with Pelotonia & AACR

Grant Amount: $206,000 USD
Grant Term: 2 Years
Start of Grant Term: September 1, 2024
Application Deadline: May 15, 2024 1:00 PM
Decision Date: August 2024

Additional information about this grant can be obtained from the Program Guidelines and Applications Instructions. Final eligibility determinations will not be completed until the AACR receives the submitted application.

Applicants must be female investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged to apply.

At the start of the grant term on September 1, 2024, applicants must:

Hold a faculty position with the title of assistant professor. Appointments such as research assistant professor, adjunct assistant professor, and assistant professor research track are eligible. Applicants that have progressed to associate professor or equivalent appointments are not eligible.
- If eligibility is based on a future position, the position must be confirmed at the time of application and CANNOT be contingent upon receiving this grant.
Have started their first independent faculty position within the past 6 years from the grant start date (i.e. cannot have held an independent faculty position before September 1, 2018).
Must devote at least 75% of their total effort to research in breast or a gynecologic cancer.
Have independent laboratory space as confirmed by their institution.

Aspire

ASPIRE | The Mark Foundation for Cancer Research

Due: May 27, 2024
Amount: $250,000/1 year
Notes: The foundation is seeking projects focused on tumors of the upper GI tract. Proposals should aim to drive disruptive research, with the goal of advancing the field of gastric and esophageal cancer research and ultimately improving patient outcomes. Proposals should cover topics such as understanding the molecular mechanisms underlying tumor initiation and progression, resistance, and metastasis; identifying novel biomarkers for early detection; and developing innovative treatment strategies including identifying and characterizing novel targets. PIs must be independent researchers at their respective institutions. Proposals from investigators at all career stages, especially those new to the field of upper GI cancers, are welcome. To facilitate this, preclinical resources (cell lines, organoids, and mouse models) will be made available to researchers who request them. Interdisciplinary collaborations are encouraged. Researchers are limited to one application as PI but may be co-investigators on other proposals without limitations.
Link: ASPIRE Award
Webinar on May 1 at 12 pm, describing application process and award.

Harrington Discovery

Alzheimer’s Drug Discovery Foundation: ADDF-Harrington Scholar Program

Due: June 3, 2024 (LOI)
Amount: $600,000 over 2 years
Notes: Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This unique award provides funding and project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and the Brain Health Medicines Centers of the Harrington Discovery Institute.

Lead investigator must have an MD, a PhD, or equivalent. Proposals should show potential to advance discovery into meaningful therapeutics to treat, prevent, slow, or reverse Alzheimer’s disease or related dementias (vascular dementia, frontotemporal dementia, Lewy Body dementia, LATE etc).

Team should possess intellectual property (IP) or have potential for novel IP that has not yet been licensed to a for-profit entity. Researchers working on drug development programs that are relevant to but not presently focused on the Alzheimer’s field are strongly encouraged to apply. Therapeutic targets with a clear marker of target engagement, either established or in development will be considered of high priority.
The ADDF-Harrington Scholar Program does not support target discovery, assay development, or high throughput screening campaigns.
Link: ADDF-Harrington Scholar Program | Alzheimer's Drug Discovery Foundation (alzdiscovery.org)

Macy Faculty Scholars Program

2025 Macy Faculty Scholars Program

Sponsored by the Josiah Macy Jr. Foundation, the Macy Faculty Scholars Program, a prestigious national award, is designed to develop and advance the careers of junior faculty medical educators. The Scholars Program annually competitively selects and funds FIVE scholars from across the nation. Albert Einstein College of Medicine may nominate ONE faculty member for consideration for the 2025 Program. Awards are intended to cover 50% protected time up to a cap of $100,000 per year for 2 years.

Eligibility criteria:

Candidates must have been awarded a doctorate in medicine, biomedical sciences, or a related field.
Nominees must be hold full-time appointments at the rank of assistant or associate professor or equivalent. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT eligible.
Candidates must NOT have been appointed as faculty at any institution prior to July 1, 2015, whether or not such appointment was on a tenure track. Time spent on clinical internships, residencies, on work towards board certification, or on parental leave does not count as part of this eight-year limit.

SAVE THE DATE: An informational webinar for applicants will be held by the Josiah Macy Jr Foundation on Wednesday, May 29 at 1:00 pm ET. RSVP Today

Application Materials

Note: The deadline for submission of preliminary applications for internal review by Einstein’s Education Awards Committee is 5 PM, June 26, 2023.

Please send ONE PDF file containing the following as an email attachment to susan.legnini@einsteinmed.edu.

Candidate Profile Form (click here).
A statement by the applicant on career objectives and personal goals for this program, limited to no more than TWO single-spaced pages.
A mentor’s statement outlining the applicant’s career potential, limited to no more than ONE single-spaced page.
A Departmental letter of support limited to no more than TWO single-spaced pages.
A written proposal containing a title and a description of the proposed educational scholarship project to be carried out during the grant period, limited to no more than THREE single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.
A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch.
Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award.

Complete guidelines for this program can be accessed by clicking here.

If you have any questions concerning this award or the application procedure, please contact susan.legnini@einsteinmed.edu.

Office of Grant Support